BioTrends is the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
By extension of our syndicated publications, BioTrends partners with clients to provide custom research solutions that allow clients to intimately understand their markets and to make informed business decisions.
BioTrends provides an email subscription service for its news releases
Please click the link below to subscribe:
Subscribe Here
RHEUMATOLOGISTS HAVE PLENTY OF CHOICE AMONG BIOLOGIC AGENTS FOR RA – WHERE WILL ACTEMRA FIND ITS NICHE?
Read more... Link
NEW STUDY BY BIOTRENDS HIGHLIGHTS CHANGES IN THE MANAGEMENT OF GOUT AND HYPERURICEMIA AMONG RHEUMATOLOGISTS AND PRIMARY CARE PHYSICIANS
STELARA IMPRESSES WITH EFFICACY DATA AND DOSING CONVENIENCE, BUT SAFETY CONCERNS LIKELY TO IMPACT NEAR TERM UPTAKE
Read more... Link
Use of AMAG’s Feraheme is on the Rise with 23% of Nephrologists Reporting Use of the Product
Read more... Link
New Report by BioTrends Research Group Will Explore the Perceptions and Expected Use of Alternative Dialysis Modalities in the US
Read more... Link
